HomeCompareHPCRF vs MRK

HPCRF vs MRK: Dividend Comparison 2026

HPCRF yields 5.05% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HPCRF wins by $56.1K in total portfolio value
10 years
HPCRF
HPCRF
● Live price
5.05%
Share price
$0.20
Annual div
$0.01
5Y div CAGR
32.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$112.9K
Annual income
$33,844.32
Full HPCRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — HPCRF vs MRK

📍 HPCRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHPCRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HPCRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HPCRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HPCRF
Annual income on $10K today (after 15% tax)
$429.40/yr
After 10yr DRIP, annual income (after tax)
$28,767.67/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, HPCRF beats the other by $20,439.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HPCRF + MRK for your $10,000?

HPCRF: 50%MRK: 50%
100% MRK50/50100% HPCRF
Portfolio after 10yr
$84.8K
Annual income
$21,821.23/yr
Blended yield
25.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HPCRF
No analyst data
Altman Z
2.5
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HPCRF buys
0
MRK buys
0
No recent congressional trades found for HPCRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHPCRFMRK
Forward yield5.05%2.76%
Annual dividend / share$0.01$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR32.5%32.7%
Portfolio after 10y$112.9K$56.8K
Annual income after 10y$33,844.32$9,798.13
Total dividends collected$83.1K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HPCRF vs MRK ($10,000, DRIP)

YearHPCRF PortfolioHPCRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,369$669.36$11,206$366.19+$163.00HPCRF
2$13,108$942.39$12,650$502.35+$458.00HPCRF
3$15,371$1,345.39$14,407$694.19+$964.00HPCRF
4$18,400$1,953.64$16,585$967.82+$1.8KHPCRF
5$22,584$2,896.07$19,342$1,363.89+$3.2KHPCRF
6$28,567$4,401.75$22,913$1,947.19+$5.7KHPCRF
7$37,461$6,894.69$27,662$2,823.89+$9.8KHPCRF
8$51,280$11,196.10$34,159$4,173.35+$17.1KHPCRF
9$73,848$18,978.49$43,337$6,308.80+$30.5KHPCRF
10$112,861$33,844.32$56,776$9,798.13+$56.1KHPCRF

HPCRF vs MRK: Complete Analysis 2026

HPCRFStock

Home Product Center Public Company Limited operates as a home improvement retailer in Thailand and Malaysia. The company trades in a range of goods and materials for construction, addition, refurbishment, renovation, and improvement of buildings, houses, and residences; and provides a range of related services. It also offers 3D, installation, maintenance, home makeover, warehousing, and distribution services. In addition, the company rents space. As of December 31, 2020, it had 115 branches. The company was founded in 1995 and is headquartered in Nonthaburi, Thailand.

Full HPCRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this HPCRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HPCRF vs SCHDHPCRF vs JEPIHPCRF vs OHPCRF vs KOHPCRF vs MAINHPCRF vs JNJHPCRF vs ABBVHPCRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.